Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620491
Title:
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.
Authors:
Hope, S. V.; Knight, B. A.; Shields, B. M.; Hill, A. V.; Choudhary, P.; Strain, W. D.; McDonald, Timothy J. ( 0000-0003-3559-6660 ) ; Jones, A. G.
Abstract:
The aim of this study was to determine whether random non-fasting C-peptide (rCP) measurement can be used to assess hypoglycaemia risk in insulin-treated type 2 diabetes.
Citation:
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia. 2017 Diabetologia
Publisher:
Springer
Journal:
Diabetologia
Issue Date:
5-Oct-2017
URI:
http://hdl.handle.net/11287/620491
DOI:
10.1007/s00125-017-4449-2
PubMed ID:
28983693
Additional Links:
https://dx.doi.org/10.1007/s00125-017-4449-2
Type:
Journal Article
Language:
en
ISSN:
1432-0428
Appears in Collections:
Exeter Clinical Laboratory International (Blood Sciences, Genetics, Cellular Pathology & Microbiology); 2017 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorHope, S. V.en
dc.contributor.authorKnight, B. A.en
dc.contributor.authorShields, B. M.en
dc.contributor.authorHill, A. V.en
dc.contributor.authorChoudhary, P.en
dc.contributor.authorStrain, W. D.en
dc.contributor.authorMcDonald, Timothy J.en
dc.contributor.authorJones, A. G.en
dc.date.accessioned2017-11-03T16:10:13Z-
dc.date.available2017-11-03T16:10:13Z-
dc.date.issued2017-10-05-
dc.identifier.citationRandom non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia. 2017 Diabetologiaen
dc.identifier.issn1432-0428-
dc.identifier.pmid28983693-
dc.identifier.doi10.1007/s00125-017-4449-2-
dc.identifier.urihttp://hdl.handle.net/11287/620491-
dc.description.abstractThe aim of this study was to determine whether random non-fasting C-peptide (rCP) measurement can be used to assess hypoglycaemia risk in insulin-treated type 2 diabetes.en
dc.language.isoenen
dc.publisherSpringeren
dc.relation.urlhttps://dx.doi.org/10.1007/s00125-017-4449-2en
dc.rightsArchived with thanks to Diabetologiaen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.titleRandom non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.en
dc.typeJournal Articleen
dc.identifier.journalDiabetologiaen
dc.type.versionIn press (epub ahead of print)en

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.